https://www.thebostonexaminer.com/article/913663708-theanswerpage-com-launches-new-cme-ce-essential-course-on-cannabis-use-disorder-and-cannabinoid-hyperemesis-syndrome The Boston Examiner en PressRelease 2026-05-20T07:00:00+00:00 TheAnswerPage.com Launches New CME/CE Essential Course on Cannabis Use Disorder and Cannabinoid Hyperemesis Syndrome https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861346-cannabis-medicine-education-lib-1536x1024.png https://www.thebostonexaminer.com/article/913810182-financial-services-at-risk-ddos-attacks-are-bigger-longer-and-more-complex-akamai-research-finds The Boston Examiner en PressRelease 2026-05-20T10:28:00+00:00 Financial Services at Risk: DDoS Attacks Are Bigger, Longer, and More Complex, Akamai Research Finds https://ml.globenewswire.com/media/4ce7685a-3da0-416d-9bc1-58cc8b7812b8/small/akamai-logo-color-rgb-bluenavy-png.png https://www.thebostonexaminer.com/article/913647570-enkrypt-ai-and-ascent-business-partners-form-strategic-partnership-to-bring-ai-governance-to-regulated-enterprises-bpos The Boston Examiner en PressRelease 2026-05-19T17:02:31+00:00 Enkrypt AI and Ascent Business Partners Form Strategic Partnership to Bring AI Governance to Regulated Enterprises, BPOs https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861155-21-1920x1270.png https://www.thebostonexaminer.com/article/913644383-fisher-college-website-ranked-among-top-5-in-the-nation-for-advertising-excellence The Boston Examiner en PressRelease 2026-05-19T16:43:18+00:00 Fisher College Website Ranked Among Top 5% in the Nation for Advertising Excellence https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861135-www-fisher-edu-1251x867.png https://www.thebostonexaminer.com/article/913641808-mayhew-tools-introduces-new-30-line-up-ironworker-bar-for-precision-heavy-duty-alignment The Boston Examiner en PressRelease 2026-05-19T16:28:08+00:00 Mayhew Tools Introduces New 30” Line-Up Ironworker Bar for Precision Heavy-Duty Alignment https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861107-mayhew-tools-30-line-up-ironwo-1200x1200.png https://www.thebostonexaminer.com/article/913641692-ultrasight-appoints-rick-geoffrion-as-chairman-of-the-board The Boston Examiner en PressRelease 2026-05-19T16:24:10+00:00 UltraSight™ Appoints Rick Geoffrion as Chairman of the Board https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/22432389-ultrasight-logo-3442x1396.png https://www.thebostonexaminer.com/article/913637437-lisc-ma-and-resonant-energy-launch-6th-phase-of-the-star-campaign-to-support-housing-organizations-going-solar The Boston Examiner en PressRelease 2026-05-19T16:14:32+00:00 LISC MA and Resonant Energy Launch 6th Phase of the STAR Campaign to Support Housing Organizations Going Solar https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861077-j-j-carrol-solar-4091x3400.jpeg https://www.thebostonexaminer.com/article/913626120-agentoutreach-io-uses-ai-to-find-and-draft-outreach-contacts-for-website-owners The Boston Examiner en PressRelease 2026-05-19T16:00:00+00:00 AgentOutreach.io Uses AI to Find and Draft Outreach Contacts for Website Owners https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24860973-agentoutreach-io-hp-17-20260519-2400x1350.png https://www.thebostonexaminer.com/article/913767252-akamai-announces-pricing-of-upsized-offering-of-convertible-senior-notes The Boston Examiner en PressRelease 2026-05-20T03:11:01+00:00 Akamai Announces Pricing of Upsized Offering of Convertible Senior Notes https://ml.globenewswire.com/media/4ce7685a-3da0-416d-9bc1-58cc8b7812b8/small/akamai-logo-color-rgb-bluenavy-png.png https://www.thebostonexaminer.com/article/913626004-kula-bio-launches-kula-n-advanced-and-kula-next-advanced-simplifying-portfolio-with-high-efficiency-liquid-formulation The Boston Examiner en PressRelease 2026-05-19T14:59:15+00:00 Kula Bio® Launches Kula-N Advanced and Kula-Next Advanced, Simplifying Portfolio with High-Efficiency Liquid Formulation https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24860971-advanced-line-1334x891.png https://www.thebostonexaminer.com/article/913548833-aptia-adds-rain-to-aptia-amplify-partners-bringing-earned-wage-access-and-financial-health-tools-to-employer-clients The Boston Examiner en PressRelease 2026-05-19T14:00:00+00:00 Aptia Adds Rain to Aptia Amplify Partners, Bringing Earned Wage Access and Financial Health Tools to Employer Clients https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23790683-aptia-logo-223x226.png https://www.thebostonexaminer.com/article/913618458-oasis-launches-single-name-space-technical-committee-to-standardize-universal-data-access The Boston Examiner en PressRelease 2026-05-19T13:56:46+00:00 OASIS Launches Single Name Space Technical Committee to Standardize Universal Data Access https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/752506-oasis-stacked-803x400.png https://www.thebostonexaminer.com/article/913344094-syndevrx-to-present-amelia-1-data-at-asco-2026-showing-improved-pi3k-akt-class-inhibitor-responses-in-breast-cancer The Boston Examiner en PressRelease 2026-05-19T13:30:00+00:00 SynDevRx to Present AMELIA™-1 Data at ASCO 2026 Showing Improved PI3K/AKT Class Inhibitor Responses in Breast Cancer https://www.thebostonexaminer.com/article/913033691-nodar-launches-flightview-a-real-time-3d-collision-warning-system-for-fixed-wing-aircraft-and-uavs The Boston Examiner en PressRelease 2026-05-19T13:19:35+00:00 NODAR Launches FlightView, a Real-Time 3D Collision Warning System for Fixed-Wing Aircraft and UAVs https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24858101-flightview-1782x1102.png https://www.thebostonexaminer.com/article/912815311-ankored-and-civicplus-partner-to-help-parks-and-recreation-directors-protect-kids-in-their-programs The Boston Examiner en PressRelease 2026-05-19T13:18:45+00:00 Ankored and CivicPlus Partner to Help Parks and Recreation Directors Protect Kids in Their Programs https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24857011-civicplus-logo-3352x428.png https://www.thebostonexaminer.com/article/913305688-aihosts-fm-launches-podcast-network-where-ai-hosts-interview-real-human-experts The Boston Examiner en PressRelease 2026-05-19T13:00:00+00:00 AIHosts.fm Launches Podcast Network Where AI Hosts Interview Real Human Experts https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24858903-aihosts-fm-hp-16-202605171112-2400x1350.png https://www.thebostonexaminer.com/article/913481008-abg-commercial-realty-facilitates-7-million-sale-of-strategic-route-9-retail-and-flex-property-in-natick-ma The Boston Examiner en PressRelease 2026-05-19T13:00:00+00:00 ABG Commercial Realty Facilitates $7 Million Sale of Strategic Route 9 Retail and Flex Property in Natick, MA https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24859952-801-worcester-sy-aerial-1024x767.jpeg https://www.thebostonexaminer.com/article/913482885-simone-lamont-honored-as-stevie-award-winner-in-2026-american-business-awards The Boston Examiner en PressRelease 2026-05-19T13:00:00+00:00 Simone Lamont Honored as Stevie® Award Winner in 2026 American Business Awards® https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24859962-stevie-award-2026-1200x630.jpeg https://www.thebostonexaminer.com/article/913502316-flipside-sells-blockchain-data-business-to-sonarx-commits-fully-to-edisyl-enterprise-ai-platform The Boston Examiner en PressRelease 2026-05-19T13:00:00+00:00 Flipside sells blockchain data business to SonarX, commits fully to edisyl enterprise AI platform https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24860131-flipside-and-sonarx-logo-stacke-1200x628.png https://www.thebostonexaminer.com/article/913608008-thrive-buildings-partners-with-cpower-to-bring-safe-scalable-demand-management-to-critical-environments The Boston Examiner en PressRelease 2026-05-19T12:36:55+00:00 Thrive Buildings Partners with CPower to Bring Safe, Scalable Demand Management to Critical Environments https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24860851-demand-response-event-305x100.png https://www.thebostonexaminer.com/article/910860415-focuspoint-launches-nexus-business-strategy-platform-that-sees-explains-and-acts-on-every-system-a-company-runs The Boston Examiner en PressRelease 2026-05-19T12:30:00+00:00 FocusPoint Launches Nexus: Business Strategy Platform That Sees, Explains, and Acts on Every System a Company Runs https://www.thebostonexaminer.com/article/913473419-skineez-reinvents-compression-with-electrolyte-infused-recovery-socks The Boston Examiner en PressRelease 2026-05-19T12:06:24+00:00 Skineez® Reinvents Compression With Electrolyte-Infused Recovery Socks https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24859530-skineezskineez-electrolyte-comp-1206x1415.jpeg https://www.thebostonexaminer.com/article/913598141-greenmen-builders-announces-comprehensive-whole-house-remodeling-in-brookline-ma The Boston Examiner en PressRelease 2026-05-19T11:37:17+00:00 Greenmen Builders Announces Comprehensive Whole House Remodeling in Brookline MA https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24860750-whole-house-remodeling-brooklin-1920x2560.jpeg https://www.thebostonexaminer.com/article/911147717-adplus-goes-public-cross-channel-ai-ad-platform-opens-to-all-after-nearly-300-beta-signups The Boston Examiner en PressRelease 2026-05-19T10:00:00+00:00 AdPlus Goes Public: Cross-Channel AI Ad Platform Opens to All After Nearly 300 Beta Signups https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850361-adplus-overview-hero-1200x628.jpeg https://www.thebostonexaminer.com/article/913440144-blancco-report-cybersecurity-anxiety-is-driving-organizations-toward-costly-data-protection-measures The Boston Examiner en PressRelease 2026-05-19T10:00:00+00:00 Blancco Report: Cybersecurity Anxiety is Driving Organizations Toward Costly Data Protection Measures https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24859526-blancco-logo-1881x563.jpeg https://www.thebostonexaminer.com/article/913693831-aura-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-05-19T20:50:52+00:00 Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg https://www.thebostonexaminer.com/article/913693629-relay-therapeutics-announces-proposed-public-offering-of-common-stock The Boston Examiner en PressRelease 2026-05-19T20:03:00+00:00 Relay Therapeutics Announces Proposed Public Offering of Common Stock https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://www.thebostonexaminer.com/article/913370044-underground-donut-tour-named-tripadvisor-s-best-food-tour-in-boston-for-2026 The Boston Examiner en PressRelease 2026-05-19T07:00:00+00:00 Underground Donut Tour Named Tripadvisor’s Best Food Tour in Boston for 2026 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24859149-fresh-cider-donuts-on-the-tour-1024x683.jpeg https://www.thebostonexaminer.com/article/913627655-travis-marcus-joins-cdm-smith-as-data-centers-transformational-growth-leader The Boston Examiner en PressRelease 2026-05-19T14:00:00+00:00 Travis Marcus joins CDM Smith as data centers transformational growth leader https://ml.globenewswire.com/media/NDFhNTExYzAtYzVhYy00OGY0LThlMDItYzJhMDg3N2Y0ODJkLTEyNDUwODEtMjAyNi0wNS0xOS1lbg==/tiny/CDM-Smith.png https://www.thebostonexaminer.com/article/913627104-cangrade-expands-ukg-partnership-putting-predictive-hiring-within-reach-for-small-and-mid-sized-businesses The Boston Examiner en PressRelease 2026-05-19T13:01:00+00:00 Cangrade Expands UKG Partnership, Putting Predictive Hiring Within Reach for Small and Mid-Sized Businesses https://ml.globenewswire.com/media/e3bc045a-7a1f-466b-a408-e3ccd5ab2417/small/cangrade-logo-png.png https://www.thebostonexaminer.com/article/913627099-acronis-expands-teamup-program-in-canada-with-rimouski-oc-anic-partnership-delivered-by-microage-rimouski The Boston Examiner en PressRelease 2026-05-19T13:00:00+00:00 Acronis Expands #TeamUp Program in Canada with Rimouski Océanic Partnership, Delivered by MicroAge Rimouski https://ml.globenewswire.com/media/3b72fc97-9808-4d8b-bc98-86f0c02f26d0/medium/acronis-teamup-in-canada.jpg https://www.thebostonexaminer.com/article/913627672-payscale-wins-gainsight-s-customer-success-transformation-of-the-year-award The Boston Examiner en PressRelease 2026-05-19T13:00:00+00:00 Payscale Wins Gainsight's Customer Success Transformation of the Year Award https://ml.globenewswire.com/media/8d98e996-808c-4de5-8b7e-15bec433c6f4/small/payscale-full-logo-dark-png.png https://www.thebostonexaminer.com/article/913627741-study-reveals-62-of-manufacturers-believe-tariffs-and-trade-barriers-threaten-quality The Boston Examiner en PressRelease 2026-05-19T13:00:00+00:00 Study Reveals 62% of Manufacturers Believe Tariffs and Trade Barriers Threaten Quality https://ml.globenewswire.com/media/7bffa292-b2e7-4426-8958-f1e71a7f43d1/small/lumafield-logolockup-black-1-png.png https://www.thebostonexaminer.com/article/913627749-uc-health-expands-access-to-liver-transplantation-with-the-paragonix-liverguard-system The Boston Examiner en PressRelease 2026-05-19T13:00:00+00:00 UC Health Expands Access to Liver Transplantation with the Paragonix LIVERguard® System https://ml.globenewswire.com/media/5b56fec1-dc1d-480e-8a0b-aa723d7e7cf9/small/paragonix-getinge-bluecenter-png.png https://www.thebostonexaminer.com/article/913627959-ccc-named-a-stevie-award-winner-for-customer-service-department-of-the-year-in-the-2026-american-business-awards The Boston Examiner en PressRelease 2026-05-19T13:00:00+00:00 CCC Named a Stevie® Award Winner for Customer Service Department of the Year in the 2026 American Business Awards® https://ml.globenewswire.com/media/448470d8-d31c-42b2-81f4-a0a5635707e7/small/ccc-logo-full-color-transparent-background-rgb-digital-use-o.png https://www.thebostonexaminer.com/article/913628079-tive-seal-now-available-globally-to-help-shippers-detect-and-prevent-in-transit-tampering-at-scale The Boston Examiner en PressRelease 2026-05-19T13:00:00+00:00 Tive Seal Now Available Globally to Help Shippers Detect and Prevent In-Transit Tampering at Scale https://ml.globenewswire.com/media/6f1b8681-efee-4d3f-8837-8e34b54e3fbe/small/tivelogo-jpg.jpg https://www.thebostonexaminer.com/article/913610007-nodthera-announces-late-breaking-oral-presentation-at-the-94th-eas-congress The Boston Examiner en PressRelease 2026-05-19T12:30:00+00:00 NodThera Announces Late-Breaking Oral Presentation at the 94th EAS Congress https://ml.globenewswire.com/media/47e7b50f-0ca3-4bf3-8a6b-753432486e1c/small/nodthera-logo-full-color-rgb-high-png.png https://www.thebostonexaminer.com/article/913610154-exascale-labs-and-compal-electronics-to-showcase-integrated-ai-infrastructure-solution-at-computex-taipei-2026 The Boston Examiner en PressRelease 2026-05-19T12:30:00+00:00 Exascale Labs and Compal Electronics to Showcase Integrated AI Infrastructure Solution at COMPUTEX Taipei 2026 https://ml.globenewswire.com/media/67242d8b-6603-429c-ab27-e5cd8a89de1c/small/exascale-jpg.jpg https://www.thebostonexaminer.com/article/913610275-lantheus-announces-presentation-of-data-at-the-2026-american-society-of-clinical-oncology-asco-annual-meeting The Boston Examiner en PressRelease 2026-05-19T12:30:00+00:00 Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/7ff76065-4799-4307-9b3d-033643bacc35/small/lantheus-logo-png.png https://www.thebostonexaminer.com/article/913518727-scribeemr-to-exhibit-ai-medical-scribing-rcm-and-coding-solutions-at-nrha-s-49th-annual-rural-health-conference The Boston Examiner en PressRelease 2026-05-19T00:13:12+00:00 ScribeEMR to Exhibit AI Medical Scribing, RCM, and Coding Solutions at NRHA’s 49th Annual Rural Health Conference https://www.thebostonexaminer.com/article/913610294-tycho-ai-redefines-tactical-autonomy-with-halley-high-speed-vtol The Boston Examiner en PressRelease 2026-05-19T12:02:37+00:00 Tycho.AI Redefines Tactical Autonomy with Halley High-Speed VTOL https://ml.globenewswire.com/media/8dbaec18-dcd2-4959-9a2f-1e5b32986798/medium/halley-group-1-vtol-uas.jpg https://www.thebostonexaminer.com/article/913609201-bone-biologics-achieves-29-month-validated-shelf-life-for-rhnell-1 The Boston Examiner en PressRelease 2026-05-19T12:00:00+00:00 Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1 https://ml.globenewswire.com/media/71331977-9b21-4d4d-a57a-365bcc236328/small/bonebiologics-jpg.jpg https://www.thebostonexaminer.com/article/913609378-black-diamond-therapeutics-to-host-webcast-for-investors-highlighting-updated-results-from-phase-2-trial-of-silevertinib-in-1l-egfrm-nsclc The Boston Examiner en PressRelease 2026-05-19T12:00:00+00:00 Black Diamond Therapeutics to Host Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC https://ml.globenewswire.com/media/b8da4d92-789b-4f0a-a1e2-2739af370155/small/bdtxlogo-pantone3135c-png-png.png https://www.thebostonexaminer.com/article/913609939-d-orbit-and-electra-ai-sign-mou-to-bring-ai-battery-intelligence-to-space The Boston Examiner en PressRelease 2026-05-19T12:00:00+00:00 D-Orbit and ELECTRA AI Sign MoU to Bring AI Battery Intelligence to Space https://ml.globenewswire.com/media/OWFkZTBiMTUtNDRjOC00YzJjLThhZWYtMTU2MzYzMDc2ZTU3LTEzMjI5MjctMjAyNi0wNS0xOS1lbg==/tiny/ELECTRA-AI.png https://www.thebostonexaminer.com/article/913610027-lifeward-appoints-dr-keith-d-rose-as-chief-medical-officer-to-support-expansion-of-neurorehabilitation-portfolio-and-advance-biomed-platform The Boston Examiner en PressRelease 2026-05-19T12:00:00+00:00 Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform https://ml.globenewswire.com/media/9343d7ac-5bc7-4a60-a2c9-a41bf7b5e007/small/lifeward-full-logo-rgb-for-web-01-jpg.jpg https://www.thebostonexaminer.com/article/913609673-vertero-advances-into-phase-1b-study-with-vt-5006-for-the-treatment-of-parkinson-s-disease The Boston Examiner en PressRelease 2026-05-19T11:30:00+00:00 Vertero Advances into Phase 1b Study with VT-5006 for the Treatment of Parkinson’s Disease https://ml.globenewswire.com/media/1f35b823-7c3a-4b49-b782-65409c4e2599/small/vertero-400x400-tm-png.png https://www.thebostonexaminer.com/article/913610002-zenas-biopharma-announces-upcoming-presentation-of-results-from-phase-3-indigo-registrational-trial-of-obexelimab-in-immunoglobulin-g4-related-disease The Boston Examiner en PressRelease 2026-05-19T11:05:00+00:00 Zenas BioPharma Announces Upcoming Presentation of Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD) at EULAR 2026 Congress https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg https://www.thebostonexaminer.com/article/913609356-cullinan-therapeutics-receives-fda-orphan-drug-designation-for-cln-049-a-novel-flt3xcd3-t-cell-engager-in-relapsed-refractory-acute-myeloid-leukemia The Boston Examiner en PressRelease 2026-05-19T11:00:00+00:00 Cullinan Therapeutics Receives FDA Orphan Drug Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia https://ml.globenewswire.com/media/3f4113d3-b651-4c00-bd96-c1ff9384b1de/small/cullinan-logo-rgb-clr-png.png https://www.thebostonexaminer.com/article/913609481-eyepoint-announces-participation-at-upcoming-investor-conferences The Boston Examiner en PressRelease 2026-05-19T11:00:00+00:00 EyePoint Announces Participation at Upcoming Investor Conferences https://ml.globenewswire.com/media/3934240c-3155-4c7d-a525-885791fdab8b/small/eypoint-new-reg-vertical-3c-rgb1-jpg.jpg https://www.thebostonexaminer.com/article/913610026-korro-selects-krro-111-as-development-candidate-for-the-potential-treatment-of-alpha-1-antitrypsin-deficiency-aatd The Boston Examiner en PressRelease 2026-05-19T11:00:00+00:00 Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD) https://ml.globenewswire.com/media/d49fc3c4-5cf6-4b89-8434-2eadfff25c26/small/korro-logo-rgb-jpg.jpg https://www.thebostonexaminer.com/article/913610250-earned-signs-top-mlb-draft-prospect-aj-gracia-as-brand-ambassador The Boston Examiner en PressRelease 2026-05-19T11:00:00+00:00 EARNED Signs Top MLB Draft Prospect AJ Gracia as Brand Ambassador https://ml.globenewswire.com/media/6882691e-a9ea-498c-9742-a291a977444d/medium/earned-x-aj-gracia.jpeg https://www.thebostonexaminer.com/article/913610257-biometrics-as-a-service-in-medical-devices-to-reach-2-7-billion-by-2030-driven-by-remote-patient-monitoring-demand The Boston Examiner en PressRelease 2026-05-19T10:59:48+00:00 Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.thebostonexaminer.com/article/913609557-akamai-ai-brand-presence-optimizes-content-and-raises-visibility-in-agentic-search The Boston Examiner en PressRelease 2026-05-19T10:30:00+00:00 Akamai AI Brand Presence Optimizes Content and Raises Visibility in Agentic Search https://ml.globenewswire.com/media/4825254f-a028-4ac0-9867-388338ee33a1/medium/akamai-ai-brand-presence.png https://www.thebostonexaminer.com/article/913590181-relay-therapeutics-announces-initial-clinical-data-demonstrating-that-zovegalisib-has-potential-for-differentiated-safety-and-efficacy-in-patients The Boston Examiner en PressRelease 2026-05-19T10:00:00+00:00 Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients with PIK3CA-Driven Vascular Anomalies https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://www.thebostonexaminer.com/article/904779583-breaking-down-barriers-northeast-health-services-brings-mental-health-services-to-billerica The Boston Examiner en PressRelease 2026-05-18T16:15:00+00:00 Breaking Down Barriers: Northeast Health Services Brings Mental Health Services to Billerica https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24836543-billerica2-1800x1800.png https://www.thebostonexaminer.com/article/913389368-visology-announces-expansion-across-greater-boston-through-its-relationship-with-stop-shop-beginning-spring-2026 The Boston Examiner en PressRelease 2026-05-18T14:15:00+00:00 Visology Announces Expansion Across Greater Boston Through Its Relationship with Stop & Shop Beginning Spring 2026 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24859449-visology-vision-centers-inside-2016x1512.jpeg https://www.thebostonexaminer.com/article/913539821-rapid-micro-biosystems-announces-pricing-of-up-to-approximately-32-million-underwritten-offering The Boston Examiner en PressRelease 2026-05-19T01:55:00+00:00 Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering https://ml.globenewswire.com/media/12585575-0b2e-4369-bf15-500b17ccb859/small/rapid-micro-biosystems-logo.png https://www.thebostonexaminer.com/article/912843599-jedox-strengthens-its-platform-for-the-ai-era-with-the-jedox-26-major-release The Boston Examiner en PressRelease 2026-05-18T13:45:00+00:00 Jedox strengthens its platform for the AI era with the Jedox 26 major release https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24857198-jedoxai-in-jedox-26-major-relea-1080x1080.png https://www.thebostonexaminer.com/article/912571814-tellubase-edici-n-semestral-h1-2026-ya-disponible-por-tellusant The Boston Examiner en PressRelease 2026-05-18T13:30:00+00:00 TelluBase Edición Semestral H1 2026 Ya Disponible por Tellusant https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24855746-shane-ezepik-1312x1055.jpeg https://www.thebostonexaminer.com/article/913506928-cullinan-therapeutics-to-present-initial-clinical-data-for-cln-978-in-treatment-refractory-rheumatoid-arthritis-and-systemic-lupus-erythematosus-at The Boston Examiner en PressRelease 2026-05-18T21:00:00+00:00 Cullinan Therapeutics to Present Initial Clinical Data for CLN-978 in Treatment-Refractory Rheumatoid Arthritis and Systemic Lupus Erythematosus at EULAR 2026 Congress https://ml.globenewswire.com/media/3f4113d3-b651-4c00-bd96-c1ff9384b1de/small/cullinan-logo-rgb-clr-png.png https://www.thebostonexaminer.com/article/913491629-wave-life-sciences-announces-positive-update-on-restoraation-2-trial-wve-006-galnac-rna-editing-achieves-mz-like-phenotype-across-both-biweekly The Boston Examiner en PressRelease 2026-05-18T20:30:00+00:00 Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing https://ml.globenewswire.com/media/b2c5e218-8ae8-4dc2-b6f2-cf55b6b3b6e0/small/wave-life-sciences-logo-jpg.jpg https://www.thebostonexaminer.com/article/913491646-precision-optics-to-participate-in-the-lytham-partners-spring-2026-investor-conference-on-may-28-2026 The Boston Examiner en PressRelease 2026-05-18T20:30:00+00:00 Precision Optics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 https://ml.globenewswire.com/media/6d86ce33-7e41-41e5-90b0-1c74cd89785e/small/precision-optics-logo-jpg.jpg https://www.thebostonexaminer.com/article/913491619-zenas-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-05-18T20:15:00+00:00 Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg https://www.thebostonexaminer.com/article/913491593-alpha-tau-announces-first-quarter-2026-financial-results-and-provides-corporate-update The Boston Examiner en PressRelease 2026-05-18T20:01:00+00:00 Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://www.thebostonexaminer.com/article/913491595-c4-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-05-18T20:01:00+00:00 C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png https://www.thebostonexaminer.com/article/913491843-akamai-announces-proposed-offering-of-convertible-senior-notes The Boston Examiner en PressRelease 2026-05-18T20:01:00+00:00 Akamai Announces Proposed Offering of Convertible Senior Notes https://ml.globenewswire.com/media/4ce7685a-3da0-416d-9bc1-58cc8b7812b8/small/akamai-logo-color-rgb-bluenavy-png.png https://www.thebostonexaminer.com/article/913491662-beam-therapeutics-presents-recently-reported-topline-clinical-data-for-beam-302-in-alpha-1-antitrypsin-deficiency-aatd-at-the-american-thoracic The Boston Examiner en PressRelease 2026-05-18T20:00:00+00:00 Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg https://www.thebostonexaminer.com/article/913491803-store-closing-sales-underway-at-warehouse-one-and-bootlegger The Boston Examiner en PressRelease 2026-05-18T19:47:43+00:00 Store Closing Sales Underway at Warehouse One and Bootlegger https://ml.globenewswire.com/media/M2JiOGMyYWMtYmQ3NC00MWQ2LTk5NmYtMGVjMmI5YWMwYzVjLTExMTAxODYtMjAyNi0wNS0xOC1lbg==/tiny/Gordon-Brothers.png https://www.thebostonexaminer.com/article/913477704-protein-synthesis-research-market-to-reach-42-8-billion-by-2031-driven-by-surging-cgt-investment The Boston Examiner en PressRelease 2026-05-18T18:33:54+00:00 Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.thebostonexaminer.com/article/913464672-upstream-bio-presents-new-data-from-phase-2-vibrant-trial-of-verekitug-demonstrating-improvement-in-asthma-symptom-control-in-participants-with-crswnp The Boston Examiner en PressRelease 2026-05-18T15:30:00+00:00 Upstream Bio Presents New Data from Phase 2 VIBRANT Trial of Verekitug Demonstrating Improvement in Asthma Symptom Control in Participants with CRSwNP and Comorbid Asthma at the ATS 2026 International Conference https://ml.globenewswire.com/media/f1393297-d0b6-4706-960f-6128bcd0c6a4/small/upstream-logo-rgb-300x300px-jpg.jpg https://www.thebostonexaminer.com/article/913452055-arbor-biotechnologies-appoints-mathew-pletcher-ph-d-as-chief-scientific-officer The Boston Examiner en PressRelease 2026-05-18T14:00:00+00:00 Arbor Biotechnologies Appoints Mathew Pletcher, Ph.D., as Chief Scientific Officer https://ml.globenewswire.com/media/68842426-d5ae-4dd2-800a-89d80ad4b3b7/small/arbor-biotech-logo-web-3-1-jpg.jpg https://www.thebostonexaminer.com/article/913439384-akari-therapeutics-to-present-at-a-g-p-s-annual-healthcare-company-showcase The Boston Examiner en PressRelease 2026-05-18T13:05:00+00:00 Akari Therapeutics to Present at A.G.P.’s Annual Healthcare Company Showcase https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg https://www.thebostonexaminer.com/article/913439362-parexel-launches-parexelai-delivering-ai-innovation-to-accelerate-clinical-development The Boston Examiner en PressRelease 2026-05-18T13:00:00+00:00 Parexel Launches ParexelAI™, Delivering AI Innovation to Accelerate Clinical Development https://ml.globenewswire.com/media/2d0652ff-a18a-4c21-b0b3-515e0c2611b5/medium/parexelai.png https://www.thebostonexaminer.com/article/913439610-alpha-tau-to-participate-in-may-investor-conferences The Boston Examiner en PressRelease 2026-05-18T12:30:00+00:00 Alpha Tau to Participate in May Investor Conferences https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg